- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.07. | Owlet Announces New $25 Million Credit Facility With Wells Fargo | 3 | pulse2.com | ||
| 01.07. | Owlet, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.06. | Owlet (OWLT) Moves 7.3% Higher: Will This Strength Last? | 2 | Zacks | ||
| OWLET Aktie jetzt für 0€ handeln | |||||
| 05.06. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.05. | Here's Why Owlet (OWLT) Crashed 60% in Q1 | 7 | Insider Monkey | ||
| 11.05. | Owlet, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 11.05. | Owlet, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Owlet, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 06.04. | Führungswechsel bei Owlet: CEO Jonathan Harris tritt zurück, Gründer Kurt Workman übernimmt | 2 | Investing.com Deutsch | ||
| 06.04. | Owlet CEO Jonathan Harris resigns, founder Kurt Workman returns | 1 | Investing.com | ||
| 06.04. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.03. | Owlet, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 09.03. | Owlet, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 09.03. | Why Is Owlet Stock Falling Monday? | 2 | Benzinga.com | ||
| 06.03. | TD Cowen lowers Owlet stock price target to $13 on Q1 guidance | 1 | Investing.com | ||
| 06.03. | Owlet's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y | 2 | Zacks | ||
| 06.03. | Northland cuts Owlet stock price target to $15 on guidance | 2 | Investing.com | ||
| 06.03. | Owlet stock dips as investors assess softer-than-expected first-quarter guidance | 2 | Seeking Alpha | ||
| 06.03. | Owlet outlines 19%-23% revenue growth target for 2026 while expanding AI, telehealth, and international markets | 2 | Seeking Alpha |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 1,262 | 0,00 % | BICO Group AB: Bulletin from the Annual General Meeting in BICO Group AB (publ) | The following resolutions were passed at the Annual General Meeting (the "AGM") of BICO Group AB (publ) ("BICO" or the "Company") held today on 7 May 2026 in Gothenburg, Sweden.
Adoption of Income Statement... ► Artikel lesen | |
| PLUS THERAPEUTICS | 3,310 | -4,34 % | Plus Therapeutics Inc.: Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide CSF Assay Platform | HOUSTON and LAKE FOREST, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company") and Genomic Testing Cooperative, LCA ("GTC") today announced a collaboration... ► Artikel lesen | |
| ORGANON | 11,790 | 0,00 % | Organon & Co. - 8-K, Current Report | ||
| QUIDELORTHO | 15,070 | -5,07 % | QuidelOrtho Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| NANO-X IMAGING | 1,120 | 0,00 % | NANO-X IMAGING LTD: New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 | New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its... ► Artikel lesen | |
| ROCKWELL MEDICAL | 6,125 | 0,00 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 2,780 | -2,46 % | Nuwellis, Inc.: Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies | MINNEAPOLIS, July 16, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,230 | +0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| NEURONETICS | 1,565 | +10,21 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| PULSE BIOSCIENCES | 23,800 | -4,80 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| OPTIMIZERX | 6,720 | +0,45 % | OptimizeRx Corporation: OptimizeRx Launches CopayCue, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent | WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 10,200 | +6,81 % | CMS-Kehrtwende bei Kostenerstattung: Canaccord bestätigt "Buy"-Rating für Orthofix Medical | ||
| PAVMED | 5,060 | -0,98 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| QTREX QUANTUM | 1,255 | -1,18 % | QTREX Quantum Ltd.: QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director | ||
| PICARD MEDICAL | 0,141 | 0,00 % | Picard Medical, Inc.: Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program | TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the... ► Artikel lesen |
Das Unternehmen OWLET INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 5,590 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OWLET INC finden Sie auf Wallstreet Online.